Test Price
2,800 AED✅ Home Collection Available
DPAGT1 Gene Congenital Disorder of Glycosylation Type 1J (CDG‑Ij) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
Pinpoint the genetic cause of CDG‑Ij with 99.9% diagnostic sensitivity. NGS sequencing of the DPAGT1 gene, UAE‑approved home collection, and ISO‑certified excellence.
تحليل جين DPAGT1 لاضطراب الغلكزة الخلقي من النوع 1J في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الخلاصة التنفيذية
- ✓ ضمان الدقة: حساسية تشخيصية تصل إلى 99.9% عبر مختبرات حاصلة على شهادة ISO 9001:2015.
- ✓ خدمات لوجستية متميزة: سحب الدم المنزلي وفق معايير سلسلة التبريد المبرّدة، يشمل خدمة الفصد المتنقل VIP.
- ✓ الإرشاد السريري: استشارة هاتفية بعد الفحص لتفسير النتائج مع خبير.
- ✓ التأمين: التحقق من التغطية التأمينية مباشرةً عبر واتساب: +971 54 548 8731.
Comprehensive Overview: DPAGT1 Genetic Test
This Next‑Generation Sequencing (NGS) test examines the entire coding region of the DPAGT1 gene, confirming or ruling out Congenital Disorder of Glycosylation Type 1J (CDG‑Ij)—a rare, inherited metabolic disease causing severe neurological deterioration. يُستخدم هذا التحليل الجيني الشامل لتأكيد تشخيص مرض CDG‑Ij وتحسين التدخل العلاجي المبكر.
| Feature | Our DPAGT1 NGS Test | Closest Alternative (Biochemical CDG Screening) |
|---|---|---|
| Precision | Mutation‑level resolution (DNA sequencing) | Pattern‑based (serum transferrin IEF) |
| Method | NGS – 100% target region coverage | Isoelectric Focusing / Mass Spectrometry |
| Turnaround | 3–4 weeks | 5–7 days |
| Clinical Value | Definitive molecular diagnosis, family planning | Screening only; requires genetic confirmation |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, DHA License 61713011:
I understand the deep uncertainty families face when a child shows unexplained neurological decline. The DPAGT1 NGS test brings clarity, differentiating CDG‑Ij from other metabolic mimics and enabling a precise, supportive care pathway. Please remember that genetic results must always be interpreted in the context of full clinical evaluation—never in isolation.
⚠️ Critical Medication Warning:
Do not discontinue or adjust any prescribed medication, including anti‑epileptics or metabolic supplements, without direct consultation with your supervising physician.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals who have already received a confirmed CDG diagnosis via enzymatic assay and do not require genetic confirmation for clinical management should not repeat this test without geneticist advice.
- Exclusion: Acute febrile illness or current metabolic crisis may affect sample stability; reschedule collection after stabilization.
- ER Red Flag: If during the home visit you develop seizures, loss of consciousness, severe hypoglycaemia or respiratory distress, call 998 or visit the nearest emergency department immediately.
- Data privacy: Test results are stored under UAE PDPL (Federal Decree‑Law No. 45/2021) with encrypted transmission.
Patient FAQ & Clinical Guidance
Q1: What exactly does the DPAGT1 gene test diagnose?
Snippet‑targeted answer: The DPAGT1 gene test definitively diagnoses congenital disorder of glycosylation type Ij, a rare neurometabolic disease causing psychomotor regression and seizures.
سؤال وجواب بالعربية: يكشف تحليل جين DPAGT1 عن الطفرات المسببة لمرض CDG‑Ij المتوارث، مما يسمح بتشخيص دقيق في حالات الاضطرابات العصبية مجهولة السبب.
Q2: How is the test performed and what sample is needed?
Snippet‑targeted answer: A simple blood draw, one drop on an FTA card, or extracted DNA is collected at home by our certified phlebotomist, then processed via NGS.
سؤال وجواب بالعربية: تُسحب عينة دم صغيرة في المنزل بواسطة مختص مرخص، وتُحفظ في بطاقة FTA، ثم تُحلل بتقنية التسلسل الجيني المتقدم.
Q3: What is the turnaround time and cost, and is insurance accepted?
Snippet‑targeted answer: Results are ready in 3 to 4 weeks at a price of 2800 AED, with direct billing verification via WhatsApp before collection.
سؤال وجواب بالعربية: تظهر النتائج خلال 3 إلى 4 أسابيع، والتكلفة 2800 درهم مع إمكانية التحقق من تغطية التأمين عبر واتساب.
UAE Regulatory & Data Privacy Compliance
- Licensed by MOHAP under facility license 9834453 – committed to the highest quality standards.
- All advertising and test claims comply with Federal Decree‑Law No. 41 of 2024 (Article 87) on medical advertising truthfulness.
- Minors’ genetic data handled under UAE Child Data Safety (CDS) Law 2026 – parental consent and strict confidentiality.
- Personal health information protected in accordance with UAE PDPL (Federal Decree‑Law No. 45/2021) and subsequent amendments.
- ISO 9001:2015 certified laboratory (Cert: INT/EGQ/2509DA/3139) – consistent quality management.
- Test methodology conforms to 2026 AI‑Enhanced Medical Datasets; LC‑MS/MS confirmatory steps integrated when needed.
Relevant Specialists: Neurologist (clinical diagnosis and management of neurological decline), Clinical Geneticist (variant classification and family counselling), and Genetic Researcher / Medical PhD (investigation of glycosylation pathways). This is intended for individuals with clinical suspicion of CDG‑Ij and is not a general screening tool.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians